COVID-19 Comes 40 Years After AIDS - Any Lesson?
Autor:
Soriano, Vicente
; Barreiro, Pablo
; Ramos, José M.
; Eirós, José M.
; Mendoza, Carmen de
Fecha:
06/2020Palabra clave:
Revista / editorial:
AIDS ReviewsTipo de Ítem:
Articulo Revista IndexadaResumen:
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. In 1981, the first cases of AIDS were reported and wide diagnostic testing helped to characterize high-risk groups and the global burden of the epidemic. With Coronavirus Disease (COVID)-19, everything has happened too fast and both cases and fatalities are huge but still uncertain in most places. Diagnostic testing of active and past SARS-CoV-2 infections needs to expand rapidly, ideally using rapid tests. COVID-19 deaths are highly concentrated in the elderly population, with a large proportion of fatalities being “with” rather than “by” SARS-CoV-2 infection. They are often the result of inadequate health care due to overwhelming demands. To date, there is no specific therapy for SARS-CoV-2 infection. Several antivirals are being tested clinically, including remdesivir, at this time the most promising. For others such as lopinavir/ritonavir, neither significant virological nor clinical benefit has been shown. Given the characteristic pulmonary cytokine storm underlying the pathogenic mechanism of severe COVID-19 pneumonia and acute respiratory distress, antiinflammatory agents are being investigated. The benefit of corticosteroids, hydroxychloroquine, etc., is limited. Monoclonal antibodies targeting different pro-inflammatory cytokines, such as tocilizumab, an anti-interleukin 6 agent, are being tried with encouraging results. Ultimately a protective vaccine will be the best response for controlling the COVID-19 pandemic.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
53 |
36 |
54 |
35 |
66 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Hospital admissions in individuals with HTLV-1 infection in Spain
Ramos, José M.; Mendoza, Carmen de; Aguilera, Antonio; Barreiro, Pablo; Benito, Rafael; Eirós, José M.; Soriano, Vicente (AIDS, 06/2020)OBJECTIVE: To examine the clinical burden and disease spectrum, as well as time trends for human T-cell leukemia virus type 1 (HTLV-1) and HTLV type 2 (HTLV-2) hospital admissions. DESIGN: Retrospective, observational study ... -
Manual de Enfermedades Infecciosas y Terapia Antimicrobiana
Artero, Arturo; Treviño, Ana; Eirós, José M.; de Mendoza, Carmen; Oteo, José A.; Barreiro, Pablo; del Pozo, José L.; Soriano, Vicente (Universidad Internacional de La Rioja, 19/05/2022)Este Manual va dirigido a los alumnos del Máster en Enfermedades Infecciosas & Terapia Antimicrobiana de la Universidad Internacional de La Rioja (UNIR). El temario se adapta al programa del título universitario y complementa ... -
Manual de Enfermedades Infecciosas y Terapia Antimicrobiana II
Artero, Arturo; Treviño, Ana; Eirós, José M.; de Mendoza, Carmen; Oteo, José A.; Barreiro, Pablo; del Pozo, José L.; Soriano, Vicente (Universidad Internacional de La Rioja, 19/05/2022)Este Manual va dirigido a los alumnos del Máster en Enfermedades Infecciosas & Terapia Antimicrobiana de la Universidad Internacional de La Rioja (UNIR). El temario se adapta al programa del título universitario y complementa ...